CryoPort Inc (CYRX)

[H2R]

Up to now, CYRX has been a very good investment. I took some gains out when it reached %100. It keeps on climbing.

I get your take on biotech investments, they can be great, they can be rough : ATRS has been good to me too. NWBO, so far, not good, but then again, the top line is not out yet, so waiting for what I expect to be great news.

I too like SoS way of analyzing companies

Cryoport reported a very strong quarter as sales increased by 83%. The key biopharma segment increased sales by 81%. This was led by a 326% increase in sales stemming from support of the commercial CAR-T products, Kymriah and Yescarta. Some $600,000 of incremental sales were recorded from the acquisition of Cryogene which closed on May 14, 2019. For the first time the Company reported positive non-GAAP EBITDA of $300,000. The Company is only a few quarters away from reaching profitability. The cash position is very strong with $94.7 million at the close of 2Q, 2019.

(Aug. 8th, the PPS was then $20.18).

Best of luck with your investments!